Chief Scientific Officer and Head of Technical Operations · Vor Biopharma Inc. (VOR)

Tirtha Chakraborty

A named executive officer of Vor Biopharma in every fiscal year CompBrief holds from FY2020 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,003,852

Salary $477,200Stock awards $129,538

FY2023: $1,309,944

3rd of 3 named executive officers at Vor Biopharma by FY2024 total.

3 named officers on file for Vor Biopharma, FY2024

Tirtha Chakraborty’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Vor Biopharma’s whole pay program stands against its peers

  • Vor Biopharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VOR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 8, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Tirtha Chakraborty’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Tirtha Chakraborty compensation by year

Vor Biopharma Summary Compensation Table · all 5 fiscal years held
In US dollars, as Vor Biopharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023FY2024
Salary$298,439$384,022$430,000$465,500$477,200
Bonus$47,600$0$0$0$0
Stock awards$0$0$403,560$265,013$129,538
Option awards$718,008$0$866,470$382,955$197,800
Non-equity incentive$111,784$138,701$172,602$179,171$190,379
Pension and deferred compensation$0$0$0$0$0
All other$2,059$17,915$20,353$17,305$8,935
Total$1,177,890$540,638$1,892,985$1,309,944$1,003,852

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vor Biopharma Inc. DEF 14A filed April 8, 2025, accession 0001193125-25-075715, and prior-year filings.

How this page was built: the Vor Biopharma Inc. filed document, accession 0001193125-25-075715. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2025.

$1.2M
$541K
$1.9M
$1.3M
$1.0M
FY20
FY21
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU43,672$48,476—
RSU26,860$29,815—
Option85,105—$2.41
Option29,459—$8.63
Option51,730—$5.55

Per the Outstanding Equity Awards at Fiscal Year-End table in Vor Biopharma Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

3 Form 4 lines since the FY2024 proxy (filed April 8, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-05-06Tax withholding—876$0.56217,416
2025-05-01Tax withholding—985$0.66219,254
2025-05-01Tax withholding—962$0.66218,292

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Vor Biopharma’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Robert AngFormer President and Chief Executive Officer$2,220,349
Eyal AttarChief Medical Officer$1,075,785
Tirtha Chakraborty · this pageChief Scientific Officer and Head of Technical Operations$1,003,852

The full Vor Biopharma compensation record

free company brief

This page is one person within Vor Biopharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Vor Biopharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Tirtha Chakraborty's compensation dossier · One-time report. No refunds.